Treatment of protein aggregation disorders

Details for Australian Patent Application No. 2004251511 (hide)

Owner Neurochem (International) Limited

Inventors Tremblay, Patrick; Mclaughlin, Richard

Agent Shelston IP

Pub. Number AU-A-2004251511

PCT Pub. Number WO2005/000288

Priority 10/871,613 18.06.04 US; 60/512,017 17.10.03 US; 60/480,918 23.06.03 US

Filing date 21 June 2004

Wipo publication date 6 January 2005

International Classifications

A61K 31/185 (2006.01) - Acids

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2005/000288 Priority application(s): WO2005/000288

10 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251522-Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases

2004251507-Amorphous metal alloy medical devices